Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $9.3 million.

  • Ultralife's Cash & Equivalents rose 3669.91% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 3669.91%. This contributed to the annual value of $6.9 million for FY2024, which is 3331.39% down from last year.
  • Per Ultralife's latest filing, its Cash & Equivalents stood at $9.3 million for Q3 2025, which was up 3669.91% from $10.9 million recorded in Q2 2025.
  • In the past 5 years, Ultralife's Cash & Equivalents registered a high of $15.9 million during Q3 2021, and its lowest value of $5.6 million during Q1 2023.
  • Its 4-year average for Cash & Equivalents is $9.9 million, with a median of $9.3 million in 2023.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 12363.73% in 2021, then tumbled by 3331.39% in 2024.
  • Quarter analysis of 4 years shows Ultralife's Cash & Equivalents stood at $15.9 million in 2021, then crashed by 35.17% to $10.3 million in 2023, then crashed by 33.31% to $6.9 million in 2024, then skyrocketed by 35.1% to $9.3 million in 2025.
  • Its last three reported values are $9.3 million in Q3 2025, $10.9 million for Q2 2025, and $8.7 million during Q1 2025.